Cargando…
Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea
Patients with amyotrophic lateral sclerosis (ALS) sometimes consider complementary and alternative medicine (CAM) because of ineffective treatment. This study investigated the prevalence and utilization pattern of CAM among patients with ALS in South Korea. Participants were recruited through homeca...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683772/ https://www.ncbi.nlm.nih.gov/pubmed/31428170 http://dx.doi.org/10.1155/2019/4217057 |
_version_ | 1783442152235204608 |
---|---|
author | Kim, Sungha Mun, Sujeong Park, Jeonghwan Choi, Sunmi Lee, Sanghun Kim, Sungchul |
author_facet | Kim, Sungha Mun, Sujeong Park, Jeonghwan Choi, Sunmi Lee, Sanghun Kim, Sungchul |
author_sort | Kim, Sungha |
collection | PubMed |
description | Patients with amyotrophic lateral sclerosis (ALS) sometimes consider complementary and alternative medicine (CAM) because of ineffective treatment. This study investigated the prevalence and utilization pattern of CAM among patients with ALS in South Korea. Participants were recruited through homecare services for mechanical ventilation in South Korea. This study comprised a face-to-face cross-sectional survey with staff members available to address any queries. Fifty-five participants were included; all had used >1 CAM treatment option for ALS symptoms. Dietary treatments were most common, followed by functional food and massages. Most participants had obtained relevant information from family members or friends. The main reason for CAM use was an expectation that symptoms will improve with CAM; most patients were unsure of the effects. CAM use was previously discontinued by the majority of patients because of unsatisfactory effects. The mean expenditure on CAM was 288,385.28 ± 685,265.14 won per month, and the mean duration of CAM use was 11.54 ± 20.09 months. The results indicate that there is a high prevalence of CAM use among ALS patients. Healthcare providers should inquire about CAM use and openly provide accurate CAM information. Further evidence of CAM efficacy is required, as is specific guidance for consulting ALS patients regarding CAM. |
format | Online Article Text |
id | pubmed-6683772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-66837722019-08-19 Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea Kim, Sungha Mun, Sujeong Park, Jeonghwan Choi, Sunmi Lee, Sanghun Kim, Sungchul Evid Based Complement Alternat Med Research Article Patients with amyotrophic lateral sclerosis (ALS) sometimes consider complementary and alternative medicine (CAM) because of ineffective treatment. This study investigated the prevalence and utilization pattern of CAM among patients with ALS in South Korea. Participants were recruited through homecare services for mechanical ventilation in South Korea. This study comprised a face-to-face cross-sectional survey with staff members available to address any queries. Fifty-five participants were included; all had used >1 CAM treatment option for ALS symptoms. Dietary treatments were most common, followed by functional food and massages. Most participants had obtained relevant information from family members or friends. The main reason for CAM use was an expectation that symptoms will improve with CAM; most patients were unsure of the effects. CAM use was previously discontinued by the majority of patients because of unsatisfactory effects. The mean expenditure on CAM was 288,385.28 ± 685,265.14 won per month, and the mean duration of CAM use was 11.54 ± 20.09 months. The results indicate that there is a high prevalence of CAM use among ALS patients. Healthcare providers should inquire about CAM use and openly provide accurate CAM information. Further evidence of CAM efficacy is required, as is specific guidance for consulting ALS patients regarding CAM. Hindawi 2019-07-25 /pmc/articles/PMC6683772/ /pubmed/31428170 http://dx.doi.org/10.1155/2019/4217057 Text en Copyright © 2019 Sungha Kim et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kim, Sungha Mun, Sujeong Park, Jeonghwan Choi, Sunmi Lee, Sanghun Kim, Sungchul Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea |
title | Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea |
title_full | Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea |
title_fullStr | Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea |
title_full_unstemmed | Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea |
title_short | Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea |
title_sort | complementary and alternative medicine use in amyotrophic lateral sclerosis cases in south korea |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683772/ https://www.ncbi.nlm.nih.gov/pubmed/31428170 http://dx.doi.org/10.1155/2019/4217057 |
work_keys_str_mv | AT kimsungha complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea AT munsujeong complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea AT parkjeonghwan complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea AT choisunmi complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea AT leesanghun complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea AT kimsungchul complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea |